FACT / 29/09/2025 by TLJ

Pfizer Inc. Q1 2025 Financial Results

  • N ews (0)
  • N ews (0)

Pfizer’s Q1 2025 results highlighted a focus on cost savings and strategic investments. The company is on track to deliver net cost savings of approximately $4.5 billion by the end of 2025. Additionally, Pfizer announced its plan to acquire Metsera, a biotechnology firm focused on obesity treatment, for up to $7.3 billion. This move is part of Pfizer’s continued investment spree following its pandemic windfall.

  • Share: